Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
25
HUM Quote, Financials, Valuation and Earnings
Last price:
$247.43
Seasonality move
:
2.06%
Day range:
$234.66 - $252.54
52-week range:
$213.31 - $475.00
Dividend yield:
1.43%
P/E ratio:
21.89x
P/S ratio:
0.26x
P/B ratio:
1.69x
Volume:
4.2M
Avg. volume:
1.9M
1-year change:
-45.32%
Market cap:
$29.8B
Revenue:
$106.4B
EPS (TTM):
$11.29
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $64.9B | $77.2B | $83.1B | $92.9B | $106.4B | |
| Revenue Growth (YoY) | 14.02% | 18.91% | 7.66% | 11.81% | 14.54% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $7.3B | $10.6B | $10.2B | $13.7B | $14.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $242M | $283M | $326M | $401M | $493M | |
| EBT. Incl. Unusual Items | $3.5B | $4.6B | $3.4B | $3.6B | $3.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $763M | $1.3B | $485M | $762M | $836M | |
| Net Income to Company | $2.7B | $3.4B | $2.9B | $2.8B | $2.5B | |
| Minority Interest in Earnings | -- | -- | -$1M | $4M | $5M | |
| Net Income to Common Excl Extra Items | $2.7B | $3.4B | $2.9B | $2.8B | $2.5B | |
| Basic EPS (Cont. Ops) | $20.20 | $25.47 | $22.79 | $22.20 | $20.09 | |
| Diluted EPS (Cont. Ops) | $20.10 | $25.31 | $22.67 | $22.08 | $20.00 | |
| Weighted Average Basic Share | $134.1M | $132.2M | $128.7M | $126.4M | $123.9M | |
| Weighted Average Diluted Share | $134.7M | $133M | $129.4M | $127.1M | $124.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.7B | $4.9B | $3.7B | $4B | $3.9B | |
| Revenue (Reported) | $64.9B | $77.2B | $83.1B | $92.9B | $106.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.7B | $4.9B | $3.7B | $4B | $3.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $20.1B | $20.7B | $22.8B | $26.4B | $29.4B | |
| Revenue Growth (YoY) | 23.61% | 3.1% | 10.16% | 15.9% | 11.26% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.6B | $1.7B | $3.5B | $3.5B | $3.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $75M | $88M | $102M | $114M | $169M | |
| EBT. Incl. Unusual Items | $1.8B | $1.6B | $1.3B | $1.1B | $651M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $450M | $120M | $107M | $256M | $155M | |
| Net Income to Company | $1.3B | $1.5B | $1.2B | $830M | $480M | |
| Minority Interest in Earnings | -- | -- | $2M | $2M | -- | |
| Net Income to Common Excl Extra Items | $1.3B | $1.5B | $1.2B | $832M | $480M | |
| Basic EPS (Cont. Ops) | $10.12 | $11.91 | $9.45 | $6.74 | $3.99 | |
| Diluted EPS (Cont. Ops) | $10.05 | $11.84 | $9.39 | $6.71 | $3.98 | |
| Weighted Average Basic Share | $132.3M | $128.5M | $126.6M | $123.4M | $120.4M | |
| Weighted Average Diluted Share | $133.2M | $129.3M | $127.4M | $124M | $120.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.8B | $1.7B | $1.4B | $1.2B | $820M | |
| Revenue (Reported) | $20.1B | $20.7B | $22.8B | $26.4B | $29.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.8B | $1.7B | $1.4B | $1.2B | $820M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $74.4B | $81.1B | $91.5B | $102.4B | $115B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $9.4B | $9.8B | $13.5B | $13.8B | $14.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $269M | $307M | $384M | $455M | $642M | |
| EBT. Incl. Unusual Items | $5.7B | $3B | $3.6B | $3.9B | $2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6B | $358M | $769M | $853M | $554M | |
| Net Income to Company | $4.2B | $2.7B | $2.8B | $3B | $1.4B | |
| Minority Interest in Earnings | -- | -- | -- | $9M | $2M | |
| Net Income to Common Excl Extra Items | $4.2B | $2.7B | $2.8B | $3B | $1.4B | |
| Basic EPS (Cont. Ops) | $31.40 | $20.83 | $22.16 | $24.23 | $11.33 | |
| Diluted EPS (Cont. Ops) | $31.20 | $20.71 | $22.05 | $24.12 | $11.29 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.9B | $3.3B | $4B | $4.4B | $2.6B | |
| Revenue (Reported) | $74.4B | $81.1B | $91.5B | $102.4B | $115B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.9B | $3.3B | $4B | $4.4B | $2.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $58.1B | $62B | $70.4B | $79.9B | $88.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $7.4B | $6.6B | $9.9B | $10B | $10.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $211M | $235M | $293M | $347M | $496M | |
| EBT. Incl. Unusual Items | $5.1B | $3.4B | $3.6B | $4B | $2.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5B | $536M | $820M | $911M | $629M | |
| Net Income to Company | $3.6B | $2.9B | $2.8B | $3B | $1.9B | |
| Minority Interest in Earnings | -- | -- | $1M | $6M | $3M | |
| Net Income to Common Excl Extra Items | $3.6B | $2.9B | $2.8B | $3B | $1.9B | |
| Basic EPS (Cont. Ops) | $27.53 | $22.90 | $22.27 | $24.35 | $15.75 | |
| Diluted EPS (Cont. Ops) | $27.36 | $22.78 | $22.16 | $24.24 | $15.71 | |
| Weighted Average Basic Share | $396.7M | $386.1M | $380M | $373M | $361.8M | |
| Weighted Average Diluted Share | $399M | $388.2M | $381.9M | $374.7M | $362.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.3B | $3.6B | $3.9B | $4.3B | $3.1B | |
| Revenue (Reported) | $58.1B | $62B | $70.4B | $79.9B | $88.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.3B | $3.6B | $3.9B | $4.3B | $3.1B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.1B | $4.7B | $3.4B | $5.1B | $4.7B | |
| Short Term Investments | $11B | $12.6B | $13.2B | $13.9B | $16.6B | |
| Accounts Receivable, Net | $1.1B | $1.1B | $1.8B | $1.7B | $2B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $16.1B | $18.4B | $18.4B | $20.6B | $23.4B | |
| Property Plant And Equipment | $2B | $2.4B | $3.1B | $3.2B | $3B | |
| Long-Term Investments | $12.4B | $14.9B | $14.1B | $15B | $17.7B | |
| Goodwill | $3.9B | $4.4B | $11.1B | $9.1B | $9.6B | |
| Other Intangibles | $177M | $329M | $2.6B | $1.8B | $1.7B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $29.1B | $35B | $44.4B | $43.1B | $47.1B | |
| Accounts Payable | $9.8B | $12.2B | $12.8B | $14.5B | $16.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $500M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $10.7B | $13.1B | $15.1B | $18B | $18.6B | |
| Long-Term Debt | $5B | $6.1B | $10.5B | $7.9B | $10.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17B | $21.2B | $28.3B | $27.7B | $30.7B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | |
| Other Common Equity Adj | $156M | $391M | $42M | -$1.3B | -$999M | |
| Common Equity | $12B | $13.7B | $16.1B | $15.3B | $16.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $23M | $59M | $56M | |
| Total Equity | $12B | $13.7B | $16.1B | $15.4B | $16.3B | |
| Total Liabilities and Equity | $29.1B | $35B | $44.4B | $43.1B | $47.1B | |
| Cash and Short Terms | $15B | $17.2B | $16.6B | $18.9B | $21.3B | |
| Total Debt | $5.7B | $6.7B | $12.5B | $11.1B | $11.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8B | $4.3B | $13.6B | $15.1B | $5.1B | |
| Short Term Investments | $12.7B | $13.7B | $13.1B | $15.1B | $19B | |
| Accounts Receivable, Net | $1.1B | $1.9B | $1.6B | $1.8B | $2.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $21.9B | $19.9B | $28.3B | $32.1B | $26.3B | |
| Property Plant And Equipment | $2.2B | $2.9B | $3.2B | $3.3B | $2.7B | |
| Long-Term Investments | $15B | $15B | $14.2B | $16.3B | $20.2B | |
| Goodwill | $4.4B | $10.8B | $9.1B | $9.5B | $9.6B | |
| Other Intangibles | $352M | $2.7B | $1.8B | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $38.5B | $45.3B | $50.8B | $55.9B | $50B | |
| Accounts Payable | $12.9B | $13.7B | $16B | $17.8B | $17B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1B | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $14.8B | $14.8B | $19B | $20.3B | $18.5B | |
| Long-Term Debt | $6.1B | $11.5B | $7.8B | $9.5B | $11.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.7B | $29B | $34.4B | $38.9B | $32.4B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | |
| Other Common Equity Adj | $370M | $145M | -$1.5B | -$1.5B | -$653M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $22M | $63M | $55M | $59M | |
| Total Equity | $15.8B | $16.3B | $16.3B | $17B | $17.6B | |
| Total Liabilities and Equity | $38.5B | $45.3B | $50.8B | $55.9B | $50B | |
| Cash and Short Terms | $20.7B | $18B | $26.7B | $30.3B | $24.1B | |
| Total Debt | $7.8B | $12.3B | $10.6B | $11.7B | $13B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.7B | $3.4B | $2.9B | $2.8B | $2.5B | |
| Depreciation & Amoritzation | $575M | $616M | $713M | $845M | $917M | |
| Stock-Based Compensation | $163M | $181M | $180M | $216M | $175M | |
| Change in Accounts Receivable | -$32M | -$85M | -$280M | -$54M | -$337M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.3B | $5.6B | $2.3B | $4.6B | $4B | |
| Capital Expenditures | $736M | $964M | $1.3B | $1.1B | $1B | |
| Cash Acquisitions | -- | -$709M | -$4.2B | $2.4B | -$233M | |
| Cash From Investing | -$1.3B | -$3.1B | -$6.6B | -$1B | -$3.5B | |
| Dividends Paid (Ex Special Dividend) | -$291M | -$323M | -$354M | -$392M | -$431M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $987M | $2.1B | $5.8B | $2B | $2.9B | |
| Long-Term Debt Repaid | -$1.1B | -$1.4B | -$2.1B | -$3.4B | -$2.4B | |
| Repurchase of Common Stock | -$1.1B | -$1.8B | -$79M | -$2.1B | -$1.6B | |
| Other Financing Activities | -$569M | -$890M | -$310M | $2B | $725M | |
| Cash From Financing | -$2.3B | -$2B | $3B | -$1.9B | -$856M | |
| Beginning Cash (CF) | $2.3B | $4.1B | $4.7B | $3.4B | $5.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.7B | $619M | -$1.3B | $1.7B | -$367M | |
| Ending Cash (CF) | $4.1B | $4.7B | $3.4B | $5.1B | $4.7B | |
| Levered Free Cash Flow | $4.5B | $4.7B | $920M | $3.5B | $3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3B | $1.5B | $1.2B | $830M | $480M | |
| Depreciation & Amoritzation | $161M | $181M | $214M | $235M | $243M | |
| Stock-Based Compensation | $47M | $48M | $80M | $53M | $53M | |
| Change in Accounts Receivable | $1.1B | $991M | $1.7B | -$395M | $1.9B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.8B | $2.8B | $8.5B | $1.3B | $1.9B | |
| Capital Expenditures | $250M | $326M | $288M | $234M | $130M | |
| Cash Acquisitions | -- | -$3.6B | $2.6B | -$34M | -$20M | |
| Cash From Investing | -$148M | -$4.3B | $1.7B | -$585M | -$1.5B | |
| Dividends Paid (Ex Special Dividend) | -$83M | -$90M | -$100M | -$109M | -$107M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$85M | $3.5B | -$65M | -- | -- | |
| Long-Term Debt Repaid | -- | -$150M | -$1.6B | -$1.4B | -$14M | |
| Repurchase of Common Stock | -$5M | -$3M | -$4M | -$379M | -$2M | |
| Other Financing Activities | -$674M | -$588M | $709M | -$1.3B | -$647M | |
| Cash From Financing | -$845M | $2.3B | -$1.8B | -$1.7B | -$770M | |
| Beginning Cash (CF) | $7.2B | $3.4B | $5.2B | $16.2B | $5.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $822M | $926M | $8.3B | -$1.1B | -$385M | |
| Ending Cash (CF) | $8B | $4.3B | $13.6B | $15.1B | $5.1B | |
| Levered Free Cash Flow | $1.6B | $2.5B | $8.2B | $1B | $1.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.2B | $2.7B | $2.8B | $3B | $1.4B | |
| Depreciation & Amoritzation | $596M | $679M | $822M | $896M | $966M | |
| Stock-Based Compensation | $173M | $184M | $221M | $185M | $186M | |
| Change in Accounts Receivable | -$293M | -$297M | $25M | -$191M | -$320M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.9B | $2.6B | $9.6B | $6B | -$3.6B | |
| Capital Expenditures | $898M | $1.2B | $1.3B | $996M | $704M | |
| Cash Acquisitions | -$709M | -$4B | $2.2B | -$274M | -$47M | |
| Cash From Investing | -$3.8B | -$6.5B | -$96M | -$3.6B | -$3.8B | |
| Dividends Paid (Ex Special Dividend) | -$314M | -$347M | -$382M | -$421M | -$434M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2B | $3.5B | $3.1B | $2.5B | $3.9B | |
| Long-Term Debt Repaid | -- | -- | -$3.9B | -$3.6B | -$261M | |
| Repurchase of Common Stock | -$90M | -$1.8B | -$1.1B | -$2.1B | -$1.3B | |
| Other Financing Activities | -$865M | -$26M | $2.9B | $486M | -$1.9B | |
| Cash From Financing | $401M | $187M | -$268M | -$776M | -$2.6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.5B | -$3.7B | $9.3B | $1.6B | -$10B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5B | $1.4B | $8.4B | $5B | -$4.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.6B | $2.9B | $2.8B | $3B | $1.9B | |
| Depreciation & Amoritzation | $456M | $519M | $628M | $679M | $728M | |
| Stock-Based Compensation | $129M | $132M | $173M | $142M | $153M | |
| Change in Accounts Receivable | -$82M | -$294M | $11M | -$126M | -$109M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.4B | $2.4B | $9.7B | $11.1B | $3.5B | |
| Capital Expenditures | $668M | $945M | $862M | $721M | $421M | |
| Cash Acquisitions | -$709M | -$4B | $2.4B | -$223M | -$37M | |
| Cash From Investing | -$3B | -$6.5B | $6M | -$2.6B | -$2.9B | |
| Dividends Paid (Ex Special Dividend) | -$239M | -$263M | -$291M | -$320M | -$323M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.1B | $3.5B | $744M | $1.2B | $2.2B | |
| Long-Term Debt Repaid | -- | -$150M | -$2B | -$2.2B | -$48M | |
| Repurchase of Common Stock | -$30M | -$36M | -$1B | -$1B | -$768M | |
| Other Financing Activities | -$285M | $579M | $3.8B | $2.3B | -$381M | |
| Cash From Financing | $1.6B | $3.7B | $444M | $1.6B | -$183M | |
| Beginning Cash (CF) | $17.3B | $11.9B | $13.5B | $35B | $16.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.9B | -$369M | $10.2B | $10.1B | $422M | |
| Ending Cash (CF) | $21.2B | $11.6B | $23.6B | $45.1B | $16.5B | |
| Levered Free Cash Flow | $4.7B | $1.4B | $8.9B | $10.4B | $3.1B | |
Get HUM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HUM
Sector
P/E ratio
21.89x
25.86x
PEG ratio
--
0.00x
P/B ratio
1.69x
1.84x
Price / LTM sales
0.26x
1.86x
Growth Metrics
HUM
Sector
Revenue growth
11.26%
7.1%
Earnings growth
-40.69%
1.82%
Revenue (5-year growth)
13.33%
8.72%
Earnings forecast
$3.39
-$0.20
Profitability
HUM
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
4.64%
-14.09%
Return on assets
2.68%
-11.79%
Return on equity
8.1%
-14.85%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
24
Estimated Next Earnings Date
Jan
29
Balance Sheet
HUM
Sector
Total cash
$24.1B
$46.9M
Short term investments
$16.6B
$44M
Total assets
$47.1B
$142M
Long term debt
$13B
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
